BCA
AGN

Burren Capital Advisors’s Allergan plc AGN Stock Holding History

Burren Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30,117
Closed -$5.33M – 3
2020
Q1 		$5.33M Sell
30,117
-940
-3% -$177K 66.38% 1
2019
Q4 		$5.94M Hold
31,057
– – 20.08% 1
2019
Q3 		$5.23M Buy
+31,057
New +$5.06M 16.76% 2
2015
Q3 		– Sell
-2,220
Closed -$674K – 12
2015
Q2 		$674K Buy
+2,220
New +$662K 1.32% 16

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Burren Capital Advisors's AGN Position: Q2 2020 in Review

Burren Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 30,117 shares — an estimated $5.33M sold.

Burren Capital Advisors first reported a position in AGN in Q2 2015 and held it in 4 quarters. The position peaked at $5.94M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Burren Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Burren Capital Advisors sold 30,117 Allergan plc shares in Q2 2020, an estimated $5.33M.
  • Burren Capital Advisors first reported a position in Allergan plc in Q2 2015 and held it in 4 quarters.
  • Burren Capital Advisors's Allergan plc position peaked at $5.94M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Burren Capital Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.